C: Metastatic Tumors [clinicaltrials_resource:NCT00667342/group/B3]
Stratum C participants had metastatic tumors.
group [clinicaltrials_vocabulary:group]
NCT00667342 measurement [clinicaltrials_resource:NCT00667342/measurement/13b46e1c97da989252c98a43d4878db2]NCT00667342 measurement [clinicaltrials_resource:NCT00667342/measurement/62b93ae8ca78d292e7f4707dc6eb72c9]NCT00667342 measurement [clinicaltrials_resource:NCT00667342/measurement/7711f5d6edccf9f67f03ed4376f7b72b]NCT00667342 measurement [clinicaltrials_resource:NCT00667342/measurement/91448e456653389ffb23b731d0b137bf]NCT00667342 measurement [clinicaltrials_resource:NCT00667342/measurement/ba99530fd076d84cf73bf060efffbcfb]
group id [clinicaltrials_vocabulary:group-id]
C: Metastatic Tumors [clinicaltrials_resource:NCT00667342/group/B3]
Stratum C participants had metastatic tumors.
Bio2RDF identifier
NCT00667342/group/B3
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:NCT00667342/group/B3
group id [clinicaltrials_vocabulary:group-id]
description
Stratum C participants had metastatic tumors.
@en
identifier
clinicaltrials_resource:NCT00667342/group/B3
title
C: Metastatic Tumors
@en
type
label
C: Metastatic Tumors [clinicaltrials_resource:NCT00667342/group/B3]
@en